rs9521649
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001845.6(COL4A1):c.615+24C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.251 in 1,611,612 control chromosomes in the GnomAD database, including 53,456 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.24 ( 4616 hom., cov: 32)
Exomes 𝑓: 0.25 ( 48840 hom. )
Consequence
COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.252
Publications
9 publications found
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 13-110209956-G-A is Benign according to our data. Variant chr13-110209956-G-A is described in ClinVar as Benign. ClinVar VariationId is 1227525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.303 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.236 AC: 35826AN: 151916Hom.: 4613 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
35826
AN:
151916
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.247 AC: 61989AN: 251132 AF XY: 0.245 show subpopulations
GnomAD2 exomes
AF:
AC:
61989
AN:
251132
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.253 AC: 368965AN: 1459578Hom.: 48840 Cov.: 33 AF XY: 0.253 AC XY: 183404AN XY: 726262 show subpopulations
GnomAD4 exome
AF:
AC:
368965
AN:
1459578
Hom.:
Cov.:
33
AF XY:
AC XY:
183404
AN XY:
726262
show subpopulations
African (AFR)
AF:
AC:
5568
AN:
33450
American (AMR)
AF:
AC:
14640
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
AC:
6243
AN:
26122
East Asian (EAS)
AF:
AC:
1279
AN:
39690
South Asian (SAS)
AF:
AC:
19770
AN:
86232
European-Finnish (FIN)
AF:
AC:
16705
AN:
53388
Middle Eastern (MID)
AF:
AC:
1440
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
289012
AN:
1109874
Other (OTH)
AF:
AC:
14308
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
13831
27662
41494
55325
69156
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
9606
19212
28818
38424
48030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.236 AC: 35850AN: 152034Hom.: 4616 Cov.: 32 AF XY: 0.239 AC XY: 17762AN XY: 74304 show subpopulations
GnomAD4 genome
AF:
AC:
35850
AN:
152034
Hom.:
Cov.:
32
AF XY:
AC XY:
17762
AN XY:
74304
show subpopulations
African (AFR)
AF:
AC:
6984
AN:
41468
American (AMR)
AF:
AC:
4741
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
847
AN:
3466
East Asian (EAS)
AF:
AC:
240
AN:
5162
South Asian (SAS)
AF:
AC:
1023
AN:
4808
European-Finnish (FIN)
AF:
AC:
3399
AN:
10568
Middle Eastern (MID)
AF:
AC:
72
AN:
292
European-Non Finnish (NFE)
AF:
AC:
18045
AN:
67974
Other (OTH)
AF:
AC:
440
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1405
2810
4215
5620
7025
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
435
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.